FTSE MIB
34.657,35 +318,03 (+0,93%) Dow Jones
39.512,84 +125,08 (+0,32%) Nasdaq
16.340,87 -5,40 (-0,03%) Nikkei 225
38.229,11 +155,13 (+0,41%) Petrolio
78,20 -1,06 (-1,34%) Bitcoin EUR
56.544,45 -1.836,79 (-3,15%)
Hercules Capital, Inc. (HTGC)
Dopo ore:
| Chiusura precedente | 19,86 |
| Aperto | 20,00 |
| Denaro | 19,90 x 900 |
| Lettera | 19,94 x 900 |
| Min-Max giorno | 19,77 - 20,01 |
| Intervallo di 52 settimane | 13,01 - 20,01 |
| Volume | |
| Media Volume | 989.451 |
| Capitalizzazione | 3,227B |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | 9,05 |
| EPS (ttm) | 2,20 |
| Prossima data utili | 01 ago 2024 - 05 ago 2024 |
| Rendimento e dividendo (futuro) | 1,92 (9,67%) |
| Data ex dividendo | 13 mag 2024 |
| Stima target 1A | 19,69 |
GlobeNewswireX4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, today announced the closing of a $115 million loan facility with Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”). The company also announced that it drew down $22.5 million upon the transaction’s closing. “This expanded loan facility creates significant financial flexibility for X4 a
GlobeNewswireCOMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that the Company has entered into a term loan agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $50 million. Kabir Nath, COMPASS Pathways Chief Executive Officer said, “COMPASS is pleased to partner with Hercules for this source of non-dilutive financing to support our COMP360 phas
